
Autonomous Pharmacovigilance Platform
CasX.ai
For CasX.ai, Quantana engineered an autonomous pharmacovigilance platform with dual AI agents for case intake, processing, quality control and E2B(R3) regulatory submission, which has processed more than 50,000 case records with 100% audit traceability.
| Figure | Outcome |
|---|---|
| 50,000 | More than 50,000 case records processed |
| 100% | 100% audit traceability |
| 50%–80% | Reported 50% to 80% reduction in pharmacovigilance cost and up to 10 times faster case processing across deployments |
| 10x | Reported 50% to 80% reduction in pharmacovigilance cost and up to 10 times faster case processing across deployments |
- Client
- CasX.ai
- Industry
- Healthcare & Life Sciences
- Region
- Global
- Engagement
- AI product engineering
- Technology
- E2B(R3), MedDRA, WHO-DD, CIOMS, XML
- Last updated
The challenge
Pharmacovigilance teams face growing volumes of Individual Case Safety Reports (ICSRs) and complex regulation, which leads to slow and inconsistent results.
Our solution
CasX.ai is an autonomous safety platform with dual AI agents that improve case intake, processing, quality control and regulatory submission.
Key capabilities
| Item | Type |
|---|---|
| Ingests structured and unstructured data such as emails, PDFs, CIOMS, XML, literature and electronic health records | Capability |
| Populates E2B(R3) fields autonomously and produces submission-ready regulatory output | Capability |
| AI-driven coding (MedDRA and WHO-DD), triage, causality, narrative creation and duplicate detection | Capability |
| A real-time quality control agent that checks regulatory compliance before submission | Capability |
| Full audit trails, with flexible workflows and integrations for pharma, biotech, CROs and BPOs | Capability |
| E2B(R3) | Technology |
| MedDRA | Technology |
| WHO-DD | Technology |
| CIOMS | Technology |
| XML | Technology |
| Stage | Summary |
|---|---|
| Challenge | Pharmacovigilance teams face growing volumes of Individual Case Safety Reports (ICSRs) and complex regulation, which leads to slow and inconsistent results. |
| Solution | CasX.ai is an autonomous safety platform with dual AI agents that improve case intake, processing, quality control and regulatory submission. |
| Outcome | More than 50,000 case records processed |
Scope and delivery
Compliance is built in for E2B(R3), EMA, FDA and CDSCO requirements.
Outcomes
- More than 50,000 case records processed
- Case processing in minutes instead of days
- 100% audit traceability
- Reported 50% to 80% reduction in pharmacovigilance cost and up to 10 times faster case processing across deployments
Related
- Guide: Private AI: Running AI on your own infrastructure, with governance for regulated enterprises.
- Guide: Enterprise AI roadmap: How to choose, score and phase AI use cases so they reach production.
- AI transformation: Roadmaps, training, AI development and governance, in five layers.
“I see Quantana as an organization built on resilience, trust, and strong values. Its seven-year journey reflects true grit and sustainable growth.”
Dr. Balaji Ommurugan, CasX.ai
Autonomous Pharmacovigilance Platform: questions and answers
What problem does CasX.ai solve?
Pharmacovigilance teams face growing volumes of Individual Case Safety Reports (ICSRs) and complex regulation, which leads to slow and inconsistent results.
How does CasX.ai work?
It is an autonomous safety platform with dual AI agents for case intake, processing, quality control and regulatory submission, with compliance built in for E2B(R3), EMA, FDA and CDSCO requirements.
What results has CasX.ai reported?
More than 50,000 case records processed, case processing in minutes instead of days, 100% audit traceability, and a reported 50% to 80% reduction in pharmacovigilance cost across deployments.
Ready to see where AI will pay off?
Get a practical roadmap: where AI will make a real difference in your business, and what it takes to get there responsibly.





